+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Aspirin protects endothelial cells from oxidant damage via the nitric oxide-cGMP pathway



Aspirin protects endothelial cells from oxidant damage via the nitric oxide-cGMP pathway



Arteriosclerosis, Thrombosis, and Vascular Biology 23(8): 1345-1351



Aspirin is known to exert cytoprotection by presently unidentified mechanisms. This study investigates the involvement of nitric oxide (NO) in antioxidant cellular protection induced by aspirin. A 24-hour incubation with hydrogen peroxide markedly reduced viability of cultured endothelial cells. Preincubation with aspirin (3 to 30 micromol/L) protected endothelial cells from hydrogen peroxide-mediated toxicity and increased viability in a concentration-dependent fashion by up to 95% of control. This effect was specific in that other nonsteroidal anti-inflammatory drugs, such as salicylate or indomethacin, did not alter hydrogen peroxide toxicity. Aspirin-induced endothelial protection was abrogated in the presence of the NO scavenger PTIO (30 micromol/L) and the inhibitor of soluble guanylyl cyclase ODQ (1 micromol/L). Moreover, the l-arginine antagonist L-NMMA (25 micromol/L), but not its D-enantiomer, led to complete inhibition of aspirin-dependent cytoprotection. Correspondingly, aspirin enhanced NO synthase activity (citrulline formation) and intracellular cyclic GMP accumulation in endothelial cells. Protein expression of endothelial NO synthase remained unaffected in the presence of aspirin. Our data suggest that endothelial NO synthase is a site of action of aspirin and that the NO/cyclic GMP system assumes a crucial function in mediating the cytoprotective action of aspirin.

(PDF emailed within 0-6 h: $19.90)

Accession: 010205211

Download citation: RISBibTeXText

PMID: 12829521

DOI: 10.1161/01.ATV.0000083296.57581.AE


Related references

Aspirin protects endothelial cells from oxidant damage via increased nitric oxide formation. Nitric Oxide 6(4): 396, June, 2002

Aspirin-induced endothelial protection is mediated via the nitric oxide-cGMP pathway. Naunyn-Schmiedeberg's Archives of Pharmacology 365(Supplement 1): R41, March, 2002

Nitric oxide/cGMP signaling pathway protects RAW264 cells against nitric oxide-induced apoptosis by inhibiting the activation of p38 mitogen-activated protein kinase. Journal of Pharmacological Sciences 101(2): 126-134, 2006

Regulation of the nitric oxide synthase-nitric oxide-cGMP pathway in rat mesenteric endothelial cells. Journal of Applied Physiology 91(6): 2553-2560, 2001

Nitric oxide/cGMP protects endothelial cells from hypoxia-mediated leakiness. European Journal of Cell Biology 87(3): 147-161, 2007

High glucose inhibits the aspirin-induced activation of the nitric oxide/cGMP/cGMP-dependent protein kinase pathway and does not affect the aspirin-induced inhibition of thromboxane synthesis in human platelets. Diabetes 61(11): 2913-2921, 2013

Nitric oxide at low concentration protects RAW264 cells against NO-induced death through NO/cGMP/PKG pathway. Japanese Journal of Pharmacology 88(Supplement 1): 140P, 2002

Nitric oxide protects mast cells from activation-induced cell death: the role of the phosphatidylinositol-3 kinase-Akt-endothelial nitric oxide synthase pathway. Journal of Leukocyte Biology 83(5): 1218-1229, 2008

Co-administration of nitric oxide-aspirin (NCX-4016) and aspirin prevents platelet and monocyte activation and protects against gastric damage induced by aspirin in humans. Journal of the American College of Cardiology 44(3): 635-641, 2004

NCX-4016, a nitric oxide-releasing aspirin, protects endothelial cells against apoptosis by modulating mitochondrial function. Faseb Journal 16(12): 1645-1647, 2002

Fibroblast growth factor 21 protects against high glucose induced cellular damage and dysfunction of endothelial nitric-oxide synthase in endothelial cells. Cellular Physiology and Biochemistry 34(3): 658-671, 2015

Simulated microgravity promotes nitric oxide-supported angiogenesis via the iNOS-cGMP-PKG pathway in macrovascular endothelial cells. Febs Letters 584(15): 3415-3423, 2010

Nitric oxide reduces T lymphocyte adhesion to human brain microvessel endothelial cells via a cGMP-dependent pathway. European Journal of Pharmacology 514(2-3): 91-98, 2005

The antihypertensive hybrid drug urapidil stimulates cGMP generation in bovine endothelial cells probably by the nitric-oxide pathway. Naunyn-Schmiedeberg's Archives of Pharmacology 354(4 SUPPL 1): R46, 1996

Prostaglandin E2 stimulates angiogenesis by activating the nitric oxide/cGMP pathway in human umbilical vein endothelial cells. Experimental & Molecular Medicine 37(6): 588-600, 2006